Impact News +++ Gubra: Gewinnwarnung – Aktie unter Druck (Der Aktionaer) +++ GUBRA Aktie +5,97%

AZENTA Aktie

>AZENTA Aktienkurs

25.5 EUR (Tradegate)

Ask: 25.6 EUR / 234 Stück

Bid: 25.4 EUR / 237 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 8 bis 22 Uhr!

AZENTA Aktie über LYNX handeln

Intraday

1 Jahr

>AZENTA Performance

1 Woche: -6,6%

1 Monat: -4,8%

3 Monate: +2,4%

6 Monate: -40,0%

1 Jahr: -43,0%

laufendes Jahr: -47,9%

>AZENTA Aktie

Name:

AZENTA INC. DL-,01

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US1143401024 / 257275

Symbol/ Ticker:

BA3 (Frankfurt) / AZTA (NASDAQ)

Kürzel:

FRA:BA3, ETR:BA3, BA3:GR, NASDAQ:AZTA

Index:

Webseite:

https://www.azenta.com/

Profil:

Azenta Inc. is a life sciences company that specia..
>Volltext..

Marktkapitalisierung:

1191.58 Mio. EUR

Unternehmenswert:

963.77 Mio. EUR

Umsatz:

519.15 Mio. EUR

EBITDA:

36.11 Mio. EUR

Nettogewinn:

-95.76 Mio. EUR

Gewinn je Aktie:

-2.09 EUR

Schulden:

45.16 Mio. EUR

Liquide Mittel:

233.73 Mio. EUR

Operativer Cashflow:

71.85 Mio. EUR

Bargeldquote:

1.31

Umsatzwachstum:

-16.48%

Gewinnwachstum:

34.88%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Div. Historie:

02.12.21 - 0.0922€
02.09.21 - 0.0922€

>weitere anzeigen...

Insiderhandel:

1 Insider kaufte innerhalb der letzten 30 Tage Aktien im Wert von 69.900 USD.

Suchwörter:

AZENTA, BROOKS AUTOMATION

Letzte Datenerhebung:

21.08.25

>AZENTA Kennzahlen

Aktien/ Unternehmen:

Aktien: 45.84 Mio. St.

Frei handelbar: 97.88%

Leerverk. Aktien: 9.74%

Rückkaufquote: 17.58%

Mitarbeiter: 3300

Umsatz/Mitarb.: 0.17 Mio. EUR

Analysten:

Analystenrating: Neutral

Kursziel: 6.91%

Bewertung:

KGV: -

KGV lG: 58.71

KUV: 2.29

KBV: 0.82

PEG-Ratio: -

EV/EBITDA: 26.69

Rentabilität:

Bruttomarge: 43.11%

Gewinnmarge: -5.27%

Operative Marge: -4.08%

Managementeffizenz:

Gesamtkaprendite: -1.47%

Eigenkaprendite: -1.74%

>AZENTA Peer Group

Es sind 601 Aktien bekannt.

>AZENTA Chart & Kurs - NASDAQ

>AZENTA News

13.08.25 - 00:01	Insiderhandel: EVP, CFO and Treasurer kauft Aktien von Azenta im Wert von 69900 USD (Insiderkauf)
	Lin, Lawrence Y. - Vorstand - Tag der Transaktion: 2025-08-11...

05.08.25 - 21:18	Azenta reaffirms 3%–5% organic growth and 300bps margin expansion for 2025 as operational turnaround advances (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

05.08.25 - 20:36	Azenta (AZTA) Q3 EPS Jumps 36% (Fool)
	Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...

05.08.25 - 12:45	Azenta Non-GAAP EPS of $0.19 beats by $0.05, revenue of $144M misses by $5.81M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

05.08.25 - 12:33	Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance (PR Newswire)
	BURLINGTON, Mass., Aug. 5, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2025. The results of B Medical Systems are treated as discontinued operations and reflected in total diluted EPS, following the Company's......

31.07.25 - 22:09	Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology (PR Newswire)
	BURLINGTON, Mass., July 31, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered a collaboration with Frenova, a division of Fresenius Medical Care, and Nephronomics, a Renal Precision Medicine company, to begin genomic sequencing and data generation for......

31.07.25 - 14:33	Fresenius Medical Care′s Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care (PR Newswire)
	Frenova and Nephronomics, a renal precision company co-founded by Fresenius Medical Care, initiate collaboration with GENEWIZ by Azenta Life Sciences Provides vital insights through sophisticated genomic sequencing and analysis of Frenova's My Reason® genomic and clinical data registry......

30.07.25 - 22:07	Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference (PR Newswire)
	BURLINGTON, Mass., July 30, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference, on Tuesday, August 12, 2025. About Azenta Life Sciences Azenta, Inc. (Nasdaq:......

23.07.25 - 22:06	Azenta Announces Fiscal 2025 Third Quarter Earnings Conference Call and Webcast (PR Newswire)
	BURLINGTON, Mass., July 23, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2025 earnings which ended on June 30, 2025, on Tuesday August 5, 2025, before the market opens. The Company will host a conference call and live webcast to discuss its financial......

13.05.25 - 22:09	Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development (PR Newswire)
	Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster. BURLINGTON, Mass., May 13, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership between GENEWIZ from Azenta Life......

07.05.25 - 19:51	Azenta targets 3%-5% organic growth and expands automation initiatives for FY2025 (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

07.05.25 - 12:48	Azenta Non-GAAP EPS of $0.05, revenue of $143M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

07.05.25 - 12:32	Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 (PR Newswire)
	BURLINGTON, Mass., May 7, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2025. The results of B Medical Systems are treated as discontinued operations and reflected in total diluted EPS, following the Company's......

06.05.25 - 17:06	Azenta Q2 2025 Earnings Preview (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

24.04.25 - 22:15	Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and Webcast (PR Newswire)
	BURLINGTON, Mass., April 24, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal second quarter 2025 earnings which ended on March 31, 2025, on Wednesday May 7, 2025, before the market opens. The Company will host a conference call and live webcast to discuss its......

24.03.25 - 21:06	Azenta Publishes its 2024 Environmental, Social, & Governance (ESG) Report (PR Newswire)
	BURLINGTON, Mass., March 24, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the publication of its annual Environmental, Social, & Governance ("ESG") report, highlighting the Company's ongoing commitment to advancing its strategy and actions aligned with key ESG......

10.03.25 - 22:09	Azenta to Participate in the Virtual KeyBanc Capital Markets Healthcare Forum (PR Newswire)
	BURLINGTON, Mass., March 10, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) announced that Lawrence Y. Lin, Executive Vice President and Chief Financial Officer, will participate in the Virtual KeyBanc Capital Markets Healthcare Forum on Wednesday, March 19, 2025, which includes a......

06.03.25 - 19:45	Is the Options Market Predicting a Spike in Azenta (AZTA) Stock? (Zacks)
	Investors need to pay close attention to Azenta (AZTA) stock based on the movements in the options market lately....

05.02.25 - 20:36	Azenta reiterates 2025 guidance with 3-5% organic growth and EBITDA margin expansion (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

05.02.25 - 13:24	Azenta beats Q1 top-line and bottom-line estimates; reaffirms FY25 outlook (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Nur übereilt bestimmt die Neigung sich. - Johann Wolfgang von Goethe

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram